Literature DB >> 378627

Differences in intrahepatic portal-systemic shunting in alcoholic and nonalcoholic liver disease as assessed by liver scan, portal pressure, and E. coli antibodies.

D R Triger, T D Boyer, A G Redeker, T B Reynolds, A D Waxman.   

Abstract

The interrelationship among portal vein pressure, 99mTc sulfur colloid liver/spleen scan abnormality, and serum E. coli antibody titers has been examined in 33 patients with alcoholic liver disease (ALD) and compared with 24 patients with liver disease not related to alcohol (non-ALD). A correlation between portal vein pressure and liver scan abnormality is seen in both groups, but for a given degree of portal hypertension there is a much greater redistribution of sulfur colloid in the ALD group (P less than 0.01). E. coli antibody titers are significantly higher in the ALD patients compared with the non-ALD patients (P less than 0.02), and they show a positive correlation with scan abnormality but not with portal vein pressure. It is suggested that the differences in scan appearance and E. coli antibody titers in these two groups of liver disease patients may be related to differences in intrahepatic shunting.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 378627     DOI: 10.1007/bf01489317

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Injection-corrosion studies of normal and cirrhotic livers.

Authors:  M R HALES; J S ALLAN; E M HALL
Journal:  Am J Pathol       Date:  1959 Sep-Oct       Impact factor: 4.307

2.  Hyperglobulinaemia in liver disease.

Authors:  D R Triger; R Wright
Journal:  Lancet       Date:  1973-06-30       Impact factor: 79.321

3.  Bacterial and dietary antibodies in liver disease.

Authors:  D R Triger; M H Alp; R Wright
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

4.  The extrahepatic uptake of radioactive colloidal gold in cirrhotic patients as an index of liver function and portal hypertension.

Authors:  B Millette; R Chartrand; P Lavoie; A Viallet
Journal:  Am J Dig Dis       Date:  1973-08

Review 5.  Measurement of portal pressure and its clinical application.

Authors:  T B Reynolds; S Ito; S Iwatsuki
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965

6.  Phagocytic activity of the liver as a measure of hepatic circulation--a comparative study using 198 Au and 99m Tc-sulfur colloid.

Authors:  H Mundschenk; A Hromec; J Fischer
Journal:  J Nucl Med       Date:  1971-11       Impact factor: 10.057

7.  The extrahepatic uptake of 198Au as an index of portal hypertension.

Authors:  J P Fernandez; R A O'Rourke; J N Cooper; G A Ewy; J C Mullen
Journal:  Am J Dig Dis       Date:  1970-10

8.  Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure.

Authors:  T D Boyer; D R Triger; M Horisawa; A G Redeker; T B Reynolds
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

9.  The 198-Au liver scan. An index of portal-systemic collateral circulation in chronic liver disease.

Authors:  D O Castell; R B Johnson
Journal:  N Engl J Med       Date:  1966-07-28       Impact factor: 91.245

10.  Escherichia coli antibody: a screening test for immunodeficiency.

Authors:  A D Webster; T Efter; G L Asherson
Journal:  Br Med J       Date:  1974-07-06
View more
  5 in total

1.  Perfused Kupffer cell mass. Correlation with histology and severity of chronic liver disease.

Authors:  J Hoefs; K Chang; F Wang; G Kanel; T Morgan; P Braunstein
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

2.  Anti-albumin antibodies in sera of patients with liver disease.

Authors:  N Tamura; T Suou; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1982-10

3.  A dynamic study of rectally absorbed ammonia in liver cirrhosis using [13N]ammonia and a positron camera.

Authors:  H Koen; K Okuda; H Musha; Y Tateno; N Fukuda; T Matsumoto; F Shisido; T Rikitake; T Iinuma; A Kurisu; N Arimizu
Journal:  Dig Dis Sci       Date:  1980-11       Impact factor: 3.199

4.  In vitro synthesis of antibody to specific bacterial lipopolysaccharide by peripheral blood mononuclear cells from patients with alcoholic cirrhosis.

Authors:  M G Mutchnick; D F Keren
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

5.  Hyperglobulinemia in alcoholic cirrhosis. Relationship with portal hypertension and intrahepatic portal-systemic shunting as assessed by Kupffer cell uptake.

Authors:  G Pomier-Layrargues; P M Huet; G Richer; D Marleau; A Viallet
Journal:  Dig Dis Sci       Date:  1980-07       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.